Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vojdani, 2020, Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases, Clin. Immunol., 217, 10.1016/j.clim.2020.108480
Talotta, 2020, Autoimmunity as the comet tail of COVID-19 pandemic, World J. Clin. Cases, 8, 3621, 10.12998/wjcc.v8.i17.3621
Goriely, 2007, From tolerance to autoimmunity: is there a risk in early life vaccination?, J. Comp. Pathol., 137, S57, 10.1016/j.jcpa.2007.04.013
Kostoff, 2020, Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety, Toxicol. Reports., 7, 51, 10.1016/j.toxrep.2020.10.016
Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N. Engl. J. Med., 10.1056/NEJMoa2034577
Marć, 2015, Nucleic acid vaccination strategies against infectious diseases, Expert Opin. Drug Deliv., 12, 10.1517/17425247.2015.1077559
Reikine, 2014, Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5, Front. Immunol, 5, 10.3389/fimmu.2014.00342
Pelka, 2016, Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology, Immunol. Rev., 269, 60, 10.1111/imr.12375
Schurz, 2019, The X chromosome and sex-specific effects in infectious disease susceptibility, Hum. Genomics, 13, 10.1186/s40246-018-0185-z
D’haese, 2020, Off the beaten path: novel mRNA-nanoformulations for therapeutic vaccination against HIV, J. Control. Release, 10.1016/j.jconrel.2020.11.009
He, 2015, Potential therapeutic targets in the process of nucleic acid recognition: opportunities and challenges, Trends Pharmacol. Sci., 36, 51, 10.1016/j.tips.2014.10.013
Vandenbroeck, 2012, Cytokine gene polymorphisms and human autoimmune disease in the era of genome-wide association studies, J. Interf. Cytokine Res., 32, 139, 10.1089/jir.2011.0103